TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
IDL Biotech AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
37,209
|
28,875
|
24,589 |
| Financial expenses |
1
|
9
|
4 |
| Earnings before taxes |
1,975
|
-3,223
|
167 |
| EBITDA |
2,580
|
-2,491
|
2,196 |
| Total assets |
25,745
|
22,667
|
26,890 |
| Current assets |
21,245
|
17,742
|
22,108 |
| Current liabilities |
7,095
|
5,424
|
6,530 |
| Equity capital |
18,587
|
17,180
|
20,299 |
| - share capital |
16,382
|
16,943
|
16,856 |
| Employees (average) |
21
|
23
|
20 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
72.2%
|
75.8%
|
75.5% |
| Turnover per employee |
1,772
|
1,255
|
1,229 |
| Profit as a percentage of turnover |
5.3%
|
-11.2%
|
0.7% |
| Return on assets (ROA) |
7.7%
|
-14.2%
|
0.6% |
| Current ratio |
299.4%
|
327.1%
|
338.6% |
| Return on equity (ROE) |
10.6%
|
-18.8%
|
0.8% |
| Change turnover |
9,289
|
4,160
|
9,288 |
| Change turnover % |
33%
|
17%
|
61% |
| Chg. No. of employees |
-2
|
3
|
4 |
| Chg. No. of employees % |
-9%
|
15%
|
25% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.